Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.11 USD | +5.28% | +55.96% | +59.13% |
03/05 | B. Riley Adjusts Aspen Aerogels Price Target to $30 From $24, Maintains Buy Rating | MT |
02/05 | Materials Slip Amid Mixed Earnings -- Materials Roundup | DJ |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 379.02 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.97 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+59.13% | 1.91B | C | ||
+14.70% | 64.97B | A- | ||
-1.61% | 47.76B | A- | ||
+14.58% | 40.72B | B+ | ||
+20.84% | 26.88B | A- | ||
+9.54% | 19.29B | C+ | ||
+1.16% | 17.53B | B+ | ||
-21.87% | 16.03B | A- | ||
+1.11% | 15.17B | B+ | ||
-11.34% | 15.06B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ASPN Stock
- Ratings Aspen Aerogels, Inc.